Eugene Choi
Neuroscience · The Ohio State University
Publications
17
Citations
1,081
Est. group size
—
Recurring co-author estimate
Active years
21
Publishing since 2005
This body of work centers on pharmacokinetics — how drugs and natural bioactive compounds (like curcumin, resveratrol, and zeaxanthin) are absorbed, metabolized, and distributed in the body — using laboratory experiments and computational modeling to predict drug behavior in animals and humans. Some publications also touch on clinical case reports of drug-induced liver toxicity and engineered immune cell therapies for cancer. The overall focus is on translating lab-based drug behavior data into predictions relevant to human dosing and safety.
Publication output has been low and irregular over the last decade, with a small peak in 2022 followed by a slowdown, averaging just over one publication per year in the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Physicochemical characterization and phase II metabolic profiling of echinochrome A, a bioactive constituent from sea urchin, and its physiologically based pharmacokinetic modeling in rats and humans
Biomedicine & Pharmacotherapy · 2023
- Impact of route-dependent phase-II gut metabolism and enterohepatic circulation on the bioavailability and systemic disposition of resveratrol in rats and humans: A comprehensive whole body physiologically-based pharmacokinetic modeling
Biomedicine & Pharmacotherapy · 2022
- Observation of curcumin-loaded hydroxypropyl methylcellulose (HPMC) oleogels under in vitro lipid digestion and in situ intestinal absorption in rats
International Journal of Biological Macromolecules · 2022
- A simple and sensitive HPLC-FL method for bioanalysis of velpatasvir, a novel hepatitis C virus NS5A inhibitor, in rat plasma: Investigation of factors determining its oral bioavailability
Journal of Chromatography B · 2022
- Factors determining the oral absorption and systemic disposition of zeaxanthin in rats: <i>in vitro</i> , <i>in situ</i> , and <i>in vivo</i> evaluations
Pharmaceutical Biology · 2022
- Development and application of a physiologically based pharmacokinetic model for entrectinib in rats and scale-up to humans: Route-dependent gut wall metabolism
Biomedicine & Pharmacotherapy · 2021
- Engineering CD70-Directed CAR-NK Cells for the Treatment of Hematological and Solid Malignancies
Blood · 2021
- A rare case of sorafenib induced liver injury in a patient with recurrent Hurthle cell carcinoma
Journal of Case Reports and Images in Oncology · 2018
- The Successful Use of N-Acetyl-cysteine to Treat Sorafenib-Induced Hepatotoxicity
The American Journal of Gastroenterology · 2017
- A Therapeutic Role for Survivin in Mitigating the Harmful Effects of Ionizing Radiation
Sarcoma · 2016
- Biomedicine & Pharmacotherapy×3
- International Journal of Biological Macromolecules×1
- Journal of Chromatography B×1
- Pharmaceutical Biology×1
- Sarcoma×1
- Robert V. Considine
Neuroscience · Indiana University
- George A. Kyriazis
Neuroscience · The Ohio State University
- Hongxia Ren
Neuroscience · Indiana University
- Kimberly P. Kinzig
Neuroscience · Purdue University West Lafayette
- Deborah A. Swartz‐Basile
Neuroscience · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile